# Effect of Probiotic Co-administration With Omega-3 Fatty Acids on NAFLD

> **NCT03528707** · NA · COMPLETED · sponsor: **Bogomolets National Medical University** · enrollment: 48 (actual)

## Conditions studied

- Type2 Diabetes
- NAFLD
- Probiotic
- Omega-3 Fatty Acids

## Interventions

- **DIETARY_SUPPLEMENT:** Symbiter-Omega
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03528707
- **Lead sponsor:** Bogomolets National Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-14
- **Primary completion:** 2015-12-22
- **Final completion:** 2016-01-28
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03528707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03528707, "Effect of Probiotic Co-administration With Omega-3 Fatty Acids on NAFLD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03528707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*